Search Results

Triflusal 5mg  | ≥99%

CSNpharm

Triflusal inhibits the production of thromboxane-B2 in platelets irreversibly by acetylating cycloxygenase-1.

More Information Supplier Page

Triflusal 10mg  | ≥99%

CSNpharm

Triflusal inhibits the production of thromboxane-B2 in platelets irreversibly by acetylating cycloxygenase-1.

More Information Supplier Page

FG-2216 10mg  | ≥99%

CSNpharm

FG-2216 is a potent HIF-prolyl hydroxylase inhibitor with IC50 of 3.9 μM for PHD2 enzyme, orally bioavailable and induced significant and reversible Epo induction in vivo.

More Information Supplier Page

FG-2216 50mg  | ≥99%

CSNpharm

FG-2216 is a potent HIF-prolyl hydroxylase inhibitor with IC50 of 3.9 μM for PHD2 enzyme, orally bioavailable and induced significant and reversible Epo induction in vivo.

More Information Supplier Page

FG-2216 5mg  | ≥99%

CSNpharm

FG-2216 is a potent HIF-prolyl hydroxylase inhibitor with IC50 of 3.9 μM for PHD2 enzyme, orally bioavailable and induced significant and reversible Epo induction in vivo.

More Information Supplier Page

FG-2216 2mg  | ≥99%

CSNpharm

FG-2216 is a potent HIF-prolyl hydroxylase inhibitor with IC50 of 3.9 μM for PHD2 enzyme, orally bioavailable and induced significant and reversible Epo induction in vivo.

More Information Supplier Page